Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2
Early elixir: brompheniramine, a first-generation antihistamine
For over 70 years brompheniramine has been used to stifle sneezes … but not for everyone.
Could domestic manufacturing fix our medicine shortage problems?
With medicine shortages set to be an issue for the foreseeable future, local medicines manufacturing could be the way forward.
Report any CAM adverse effects, warns Dr Geraldine Moses
Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.
Antibiotic prescribing is reaching dangerous levels, warns report
Antibiotic use has crept back up since COVID-19 restrictions have lifted, with multi-resistant bugs increasingly in our midst.
Podcast: Migraine and the gender pain gap
Migraine is sometimes misunderstood as a ‘women’s disorder’, which presents barriers to diagnosis, treatment and research investment.














